AQUABOUNTY TECHNOLOGIES

AQBNASDAQ

🏆 #3985 by market capEarnings Nov 10US Equity

$1.49▲ $0.13 (+8.76%)

🌙 After hours$1.49▲ 0.00%Regular close · extended-hours price shown

1h—

24h▲ 8.8%

7d▲ 55.6%

14d▲ 55.6%

30d▲ 56.7%

1y▲ 101.4%

🏦Market Cap

$8M

Small Cap

📈Revenue Growth (YoY)

+0.0%

Slowing

📊Gross Margin

0.0%

Thin

💵FCF Margin

0.0%

Thin

⚖️P/S Ratio

0.0x

Cheap

Otter Score

Weak

Trading Snapshot

Day Range: $1.48 – $1.51
52-Week Range: $0.70 – $2.95
Volume: $3.53B
Avg Volume: $2.84B
Shares Outstanding: 5.1M
Next Earnings: Sep 14, 2026

Fundamentals Snapshot

Annual Revenue: $2M
Last Q Revenue: $372,486
P/E Ratio: -0.3
P/S Ratio: 0.0x
EPS (TTM): $-3.56
Dividend Yield: 0.00%

Why Investors Own AQB

✓High-growth profile — revenue up -5.3% YoY with expanding US Equity exposure.
✓Healthy economics — 71% gross margin and 7% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$2M▼ −8.7% YoY

Gross Margin (TTM)

70.6%▲ +4.4% YoY

Operating Income (TTM)

$369,662▼ −8.7% YoY

Free Cash Flow (TTM)

$101,235▼ −8.7% YoY

About AQUABOUNTY TECHNOLOGIES

AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.

🦦